Compare R & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | R | XENE |
|---|---|---|
| Founded | 1933 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.3B |
| IPO Year | 1994 | 2014 |
| Metric | R | XENE |
|---|---|---|
| Price | $233.64 | $57.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $238.56 | $68.55 |
| AVG Volume (30 Days) | 370.9K | ★ 789.2K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | ★ 7.96 | N/A |
| EPS | ★ 2.33 | N/A |
| Revenue | ★ $12,665,000,000.00 | $311,000.00 |
| Revenue This Year | $5.00 | N/A |
| Revenue Next Year | $5.05 | $2,496.48 |
| P/E Ratio | $100.30 | ★ N/A |
| Revenue Growth | ★ 0.23 | N/A |
| 52 Week Low | $139.89 | $28.19 |
| 52 Week High | $259.00 | $62.91 |
| Indicator | R | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 57.77 |
| Support Level | $179.63 | $39.93 |
| Resistance Level | N/A | $59.71 |
| Average True Range (ATR) | 8.96 | 1.90 |
| MACD | 0.49 | -0.28 |
| Stochastic Oscillator | 48.14 | 66.29 |
Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.